Document Detail


Comparative effects of 5% ethanolamine oleate versus 5% ethanolamine oleate plus 1% polidocanol for sclerosing esophageal varices.
MedLine Citation:
PMID:  1483669     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Sixty-six patients with portal hypertension and esophageal varices due to liver cirrhosis were randomized to receive either 5% ethanolamine oleate (EO) or 5% EO plus 1% polidocanol (EOP) as a sclerosant for endoscopic injection sclerotherapy (EIS). The two groups were well matched with regard to age, sex and the severity of liver disease. In no patient in the two groups was there any major complication, such as esophageal perforation or esophageal bleeding. Eradication of esophageal varices was attained with an average of 4.7 and 4.3 sessions of endoscopic injection sclerotherapy in the ethanolamine oleate and polidocanol groups, respectively. Data on one patient in the ethanolamine oleate group had to be excluded because he left the hospital after 2 sessions of endoscopic injection sclerotherapy. Esophageal ulcers occurred earlier in the polidocanol group (after an average of 2.8 weeks) than in the ethanolamine oleate group (3.8 weeks), the difference being statistically significant (P < 0.01). The rate of occurrence of esophageal stricture requiring more than 2 sessions of bougienage was significantly (P < 0.01) higher in the polidocanol group (16/33, 48%) than in the ethanolamine oleate group (4/32, 12%). This study suggests that the two sclerosants have equal efficacy for treating patients with esophageal varices. With polidocanol there was ulceration and stricture in the distal esophagus.
Authors:
S Kitano; H Wada; K Tanoue; M Hashizume; N Koyanagi; K Sugimachi
Related Documents :
9034929 - Circadian occurrence of variceal bleeding in patients with liver cirrhosis.
16496319 - Improved prognosis for patients hospitalized with esophageal varices in sweden 1969-2002.
7006779 - Bleeding varices: 1. emergency management.
2368549 - Tetracycline sclerotherapy of hydroceles and epididymal cysts. long-term results.
21097489 - Parent and teacher ratings of attention during a year-long methylphenidate trial in chi...
1483669 - Comparative effects of 5% ethanolamine oleate versus 5% ethanolamine oleate plus 1% pol...
24785989 - Solifenacin is able to improve the irritative symptoms after transurethral resection of...
9538979 - Effects of lisinopril and nifedipine on the progression to overt albuminuria in iddm pa...
20739409 - Primary arterial switch operation for transposition of the great arteries with intact v...
Publication Detail:
Type:  Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial    
Journal Detail:
Title:  Hepato-gastroenterology     Volume:  39     ISSN:  0172-6390     ISO Abbreviation:  Hepatogastroenterology     Publication Date:  1992 Dec 
Date Detail:
Created Date:  1993-02-17     Completed Date:  1993-02-17     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  8007849     Medline TA:  Hepatogastroenterology     Country:  GERMANY    
Other Details:
Languages:  eng     Pagination:  546-8     Citation Subset:  IM    
Affiliation:
Department of Surgery II, Kyushu University, Faculty of Medicine, Fukuoka, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Drug Combinations
Esophageal and Gastric Varices / therapy*
Esophagoscopy
Female
Humans
Male
Middle Aged
Oleic Acids / administration & dosage*
Polyethylene Glycols / administration & dosage*,  adverse effects
Sclerosing Solutions / therapeutic use*
Sclerotherapy*
Chemical
Reg. No./Substance:
0/Drug Combinations; 0/Oleic Acids; 0/Polyethylene Glycols; 0/Sclerosing Solutions; 3282-75-5/ethanolamine oleate; 9002-92-0/polidocanol

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Double-blind randomized clinical trial comparing neomycin and placebo in the treatment of exogenous ...
Next Document:  Importance of direct hepatocytolysis by liver macrophages in experimental fulminant hepatitis.